trial fibrillation (AF) is the most frequent reason for hospital admission and is also the most common sustained cardiac arrhythmia, occurring in 0.4% of the adult population. 1,2 Its prevalence is age-related and increases significantly to 1-4% after 60 years of age. [1][2][3] Owing to the age structure of Turkey's population and the increasing morbidity and comorbidity, one must assume that this arrhythmia will reach an even higher prevalence. AF is associated with a significantly higher risk of systemic embolism, congestive heart failure and death. [1][2][3][4] AF and hypertension are 2 prevalent, and often coexisting, conditions in the adult population. 5-7 Their incidence increases with age, and they are responsible for considerable morbidity and mortality. 5,6 The purpose of the present study was to determine whether a strategy that attempts to restore and maintain sinus rhythm (SR) in AF will improve survival and exercise capacity among patients with hypertension.
MethodsPatients aged >18 years who had hypertension and persistent AF for >48 h were included in the study. AF was defined as having: an absence of P-waves, course or fine fibrillatory waves, and completely irregular R-R intervals.The diagnosis of essential hypertension was defined as having BP >140/90 mmHg, or current use of antihyperten- Patients suffering from valvular heart diseases, coronary artery disease, heart failure, thyroid disease, renal failure, sick sinus syndrome, pulmonary embolism, acute pericarditis, diabetes mellitus, chronic obstructive lung disease, hypertrophic obstructive cardiomyopathy and atrial thrombus were excluded from the study.The patients were randomly assigned to either the rhythm control group or rate control group. The patients were kept under observation for a minumum follow-up period of 3 years, with regular weekly visits in the 1 st month and then once a month thereafter. The composite endpoints of the study were embolism, death and exercise capacity for both groups.At baseline, resting 12-lead ECG was obtained, and transthoracic echocardiography (TTE), transesophageal echocardiograph (TEE) and exercise tests were performed. At every control visit, a 12-lead ECG was taken. At the end of the 1 st year all patients underwent exercise testing.The TTE and TEE studies were performed with an Acuson 128 XP/5 ultrasound system. M-mode TTE was used to measure the left atrial dimension at end-systole and the LVEF, according to the recommendations of the American Society of Echocardiography. Food consumption was stopped at least 4 h before the TEE was done. Patients received local pharyngeal anesthesia (1% lidocaine spray) as the only premedication, and were given effective anticoagulation either with heparin or warfarin (INR levels 2.0-3.0 or APTT 2 times control, 60-80 s) before the TEE. Patients in whom the TEE did not detect any thrombus were cardioverted to SR. For cardioversion (CV), amiodarone (administered intravenously (iv)) was used (300 mg over 1 h, then 15-20 mg/kg for the remaining 23 h). If CV was not ach...